Stock data
Intensity Therapeutics, Inc. (INTS)
Intensity Therapeutics, Inc. (INTS) reported net income of -US$11.61M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$11.97M | -US$11.61M | — |
| 2024 | — | — | -US$16.59M | -US$16.27M | — |
| 2023 | — | — | -US$8.32M | -US$10.54M | — |
| 2022 | — | — | -US$7.55M | -US$7.58M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$3.01M | — |
| 2026-03-31 | — | -US$2.43M | — |
| 2025-12-31 | — | -US$3.05M | — |
| 2025-09-30 | — | -US$2.67M | — |
| 2025-06-30 | — | -US$2.54M | — |
| 2025-03-31 | — | -US$3.35M | — |
| 2024-12-31 | — | -US$3.18M | — |
| 2024-09-30 | — | -US$3.51M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.